MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....also known as oral and nasal metered dose inhalers respectively or MDIs) and inhalation.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and.....preservative in single dose drug products. The results of the preservative effectiveness.....This section should contain information on the final drug product including all drug substances..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=67)

Submission of an Investigational New Drug Application to OGD
...If a multiple-dose study is to be conducted on a controlled release drug..product on which no single dose study has been.....The study involves a cytotoxic drug product. An IND is required to conduct a bioavailability or.....The maximum single or total daily dose in a single dose study in normal..subjects or patients exceeds that..
http://www.fda.gov/cder/mapp/5240-4.pdf (score=46)

...For a BE determination of an oral product with a long half-life drug, a nonreplicate, single-dose, crossover study can.....Systemic exposure patterns reflect both release of the drug substance from the drug product and a series of possible.....Single-Dose/Multiple-Dose Studies Instances where multiple-dose studies can be useful are..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=46)

...No extensive dose range and dose adjustment studies with this drug product in normal and special populations have been.....This drug product has been used to measure deoxyglucose metabolism in a variety of tissues, e.g.....Optimal visual and contrast quality for imaging times and sequences vary with dose..
http://www.fda.gov/ohrms/dockets/dockets/98d0266/ref0001l.doc (score=46)

Federal Register: August 14, 1997 (Volume 62, Number 157
...A citizen petition claiming that a particular drug product is not subject to the new drug.....It is particularly important to increase the dose very gradually in patients with myxedema.....A citizen petition that contends that a particular drug product is not subject to the new drug..
http://www.fda.gov/cder/fedreg/fr14au97-83.htm (score=44)

Guidance for Industry - Content and Format of Chemistry, Manufacturing and...
...This section should contain information on the final drug product including all drug substances.....A rationale should be provided for the inclusion of a preservative in single dose drug products.....If the drug product is frozen, data supporting the stability of the product through a stated..
http://www.fda.gov/cber/gdlns/cmcvacc.htm (score=41)

Microsoft Word - 5341fnl.doc
...pharmacological effect or clinical benefit effect in relation to dose or drug concentration.The.....changed intentionally relative to an approved product, generally an immediate-release.....situations, generally involving a very well-tolerated drug with little dose-related..
http://www.fda.gov/cder/guidance/5341fnl.pdf (score=39)

Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products...
...A fixed-dose combination product is one in which two or more separate drug ingredients are combined in a.....This evaluation provides the link between the new combination drug product and the drug.....The optimal study design would be a randomized, single-dose, two-way crossover, in which..
http://www.fda.gov/oc/initiatives/hiv/hivguidance.html (score=38)

Guidance for Industry: Exposure-Response Relationships — Study Design, Data...
...There are some situations, generally involving a very well-tolerated drug with little dose-related toxicity.....New dose regimens, dosage forms and formulations, routes of administration, and minor.....Captopril, for example, was a generally well-tolerated drug that caused dose and concentration-related..
http://www.fda.gov/cber/gdlns/exposure.htm (score=36)

Guidance for Industry Exposure-Response Relationships: Study Design, Data...
...pharmacological effect or clinical benefit effect in relation to dose or drug.....changed intentionally relative to an approved product, generally an immediate-release.....situations, generally involving a very well-tolerated drug with little dose-related..
http://www.fda.gov/cber/gdlns/exposure.pdf (score=36)

MiscParts.fp5
...AVASTIN or any component of this drug product. 500 mg/m2 IV, and leucovorin 20 mg/m2 IV given.....Dose Modifications) Patients with moderate to severe proteinuria based on 24-hour.....that are two-fold greater than the recommended human dose on a mg/kg basis. Hemic..
http://www.fda.gov/medwatch/SAFETY/2004/avastin_PI.pdf (score=36)

FDA HIV/AIDS List Serve Archive, Office of Special Health Issues
...The following observations were made from a randomized, open-label, multiple-dose drug.....It is the first approval in the United States of a generic antiretroviral product to treat.....FDA's Guidance for Industry Fixed Dose Combination and Co-Packaged Drug Products for Treatment of HIV provides simplified..
http://www.fda.gov/oashi/aids/listserve/listserve2004.html (score=36)

FR Doc 03-5205
...We are proposing a new rule that would require human drug product and biological product labels.....5 percent improvement in errors caused by the incorrect dose being administered to a.....For example, if you make a prescription drug product, you would be subject to the bar coding..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-5205.html (score=36)

þÿ
...infonnation has been presented to demonstrate that the drug product is safe and effective for.....In steady-state dose proportionality studies involving elderly and nonelderly patients, at.....These supplemental new drug applications provide for the following changes to product..
http://www.fda.gov/cder/ogd/rld/20710s8.PDF (score=36)

/a/content.30891
...rate and extent of drug absorption, its pharmacokinetics, 16.. pharmacodynamics, and the.....product for the first time without doing in vivo testing, 25.. and the answer to that is.....Now, if you don't want to go along the dose axis, 5.. you can go vertically. In other..
http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3657t2.pdf (score=35)

Guidance for Industry
...would not significantly increase the risk associated with the labeled use of a drug.....Because effectiveness is often related to dose, a dose close to the maximal tolerated dose.....3 New Drug, Antibiotic, and Biologic Drug Product Regulations, Federal Register, March 19..
http://www.fda.gov/cder/guidance/6036fnl.pdf (score=32)

Guidance for Industry: IND Exemptions for Studies of Lawfully Marketed Drug...
...associated with the labeled use of a drug product and the study could be conducted without an.....This same dose usually becomes the recommended dose in labeling when the new cancer drug is approved with the knowledge that the dose.....Studies of high-dose therapy in cancer patients are likely to be considered exempt if the..
http://www.fda.gov/cber/gdlns/indcancer.htm (score=31)

Guidance for Industry: IND Exemptions for Studies of Lawfully Marketed Drug...
...increase the risk associated with the labeled use of a drug product and the study could be.....Because effectiveness is often related to dose, a dose close to the maximal tolerated dose.....3 New Drug, Antibiotic, and Biologic Drug Product Regulations, Federal Register, March 19..
http://www.fda.gov/cber/gdlns/indcancer.pdf (score=31)

FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...To qualify for these statutory exemptions, a compounded drug product must satisfy several.....Metered dose inhalers are sophisticated drug delivery systems that require extensive.....One requirement is that the drug product may only be compounded if we have not identified it..
http://www.fda.gov/cder/fdama/difconc.htm (score=31)

Las Vegas Injury Lawyer